Work

Cetuximab (Erbitux)

Year: 2010
Type: article
Abstract: Cetuximab, a recombinant chimeric monoclonal antibody, has been successfully used in the treatment of the head and neck and colorectal cancers. We present a review of its mechanism of action, indications, side effects and economic issues, accompanied by a clinical example from our institution.
Authors: W. Bou-Assaly, S. Mukherji
Language: German
Subfield: Immunology
Open Access status: hybrid
OpenAlex ID: W4253593059
FWCI: 0.826
Cites: 14
Cited by: 90
Related to: 9